Abstract
The relevance of clinical trials (CTs) is determined by their key role in the development of modern medicine and healthcare. The objective: to summarize the impact of CTs on the Ukrainian healthcare system in the context of a full-scale war, to outline regulatory transformations, organizational models for the continuation of CTs, ethical and security challenges, as well as the consequences for patient access to innovative therapies and system sustainability. Materials and methods. The work used methods of analytical review of scientific publications, international recommendations, regulatory and legal acts of the Ministry of Health (MOH) of Ukraine, as well as reports of the State Expert Center (SEC) of the MOH. Sources were selected according to the criteria of relevance (2020–2025), availability of data on the impact of crisis conditions on CTs and their areas of application. A narrative review of regulatory legal acts, analytical reports of the SEC of the Ministry of Health of Ukraine, documents of the EMA (European Medicines Agency), the EC (European Commission / Ethics Committee), as well as the CTCG (Clinical Trial Coordination Group). A review of publications in peer-reviewed journals (The Lancet, JCO Global Oncology, Human Reproduction Update, Fertility and Sterility) and professional reports of ECO (European Cancer Organisation), American Society of Clinical Oncology (ASCO), IFFS (International Federation of Fertility Societies), UNFPA (United Nations Population Fund). Results. Despite a significant reduction in the number of active CTs in 2022–2023, the sector has taken some steps to adapt through accelerated examinations, harmonization of the CT Procedure with European requirements, the introduction of risk-based and decentralized management, participant transfer, and flexible monitoring. Conclusions. It has been established that CTs during wartime perform a dual role: 1) ensure patient access to potentially life-saving interventions; 2) serve as a driver of regulatory convergence and increase the resilience of the healthcare system. The review suggests that further steps are needed, including institutionalization of crisis protocols, digitalization of procedures, development of a national infrastructure of decentralized CTs, and international data coordination.